Mesoblast Limited (MESO) Financials

MESO Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 ? ?
2023-06-30 669.4 million 167.6 million
2023-03-31 650.4 million 168.3 million
2022-12-31 668.1 million 168.1 million

MESO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -14.4 million ?
2023-06-30 -16.3 million 1.1 million
2023-03-31 -16.3 million 791000
2022-12-31 -16.5 million 1.4 million

MESO Net Income

No data available :(

MESO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 - - -
2023-06-30 70.9 million - 7.7 million
2023-03-31 48.6 million - 8.3 million
2022-12-31 67.2 million - 8.9 million

MESO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 ?
2023-06-30 144.6 million
2023-03-31 147.3 million
2022-12-31 147.3 million

MESO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 185000 - - -
2023-06-30 37000 6.7 million 5.7 million 8.7 million
2023-03-31 40000 7.1 million 6.4 million 6.2 million
2022-12-31 34000 7.7 million 6.4 million 7.9 million

MESO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 2.1 million 8.7 million
2023-03-31 1.9 million 6.2 million
2022-12-31 2.0 million 251000

MESO

Price: $7.50

52 week price:
1.61
10.24

Earnings Per Share: -0.87 USD

P/E Ratio: -2.20

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 45251

Ebitda: -19.5 million

Market Capitalization: 493.8 million

Links: